The PE Ratio as of May 2025 (TTM) for Atossa Therapeutics, Inc. (ATOS) is -4.35

According to Atossa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.35. This represents a change of -16.30% compared to the average of -5.20 of the last 4 quarters.

Atossa Therapeutics, Inc. (ATOS) Historical PE Ratio (quarterly & annually)

How has ATOS PE Ratio performed in the past?

The mean historical PE Ratio of Atossa Therapeutics, Inc. over the last ten years is -2.32. The current -4.35 PE Ratio has changed 18.61% with respect to the historical average. Over the past ten years (40 quarters), ATOS's PE Ratio was at its highest in in the September 2016 quarter at 7.76. The PE Ratio was at its lowest in in the June 2021 quarter at -27.29.

Atossa Therapeutics, Inc. (ATOS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Atossa Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Atossa Therapeutics, Inc. (ATOS) Average PE Ratio

How has ATOS PE Ratio performed in the past?

The current PE Ratio of Atossa Therapeutics, Inc. (ATOS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Atossa Therapeutics, Inc. (ATOS) PE Ratio vs. Peers

How is ATOS’s PE Ratio compared to its peers?

Atossa Therapeutics, Inc.’s PE Ratio is less than Novavax, Inc. (2.45), less than Vaxart, Inc. (-1.84), less than Inovio Pharmaceuticals, Inc. (-0.00), less than Enveric Biosciences, Inc. (-0.23), less than CohBar, Inc. (-0.10), less than Tonix Pharmaceuticals Holding Corp. (-1.36), less than Sonnet BioTherapeutics Holdings, Inc. (-0.33), less than Onconova Therapeutics, Inc. (-0.01), less than Palisade Bio, Inc. (-0.28), less than iBio, Inc. (-0.37), less than Jaguar Health, Inc. (-0.07), less than GeoVax Labs, Inc. (-0.50), greater than Ocugen, Inc. (-4.64), less than AVROBIO, Inc. (-0.36), less than Ocean Biomedical, Inc. (-0.01), less than Elevation Oncology, Inc. (-0.40),

Build a custom stock screener for Atossa Therapeutics, Inc. (ATOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atossa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atossa Therapeutics, Inc. (ATOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atossa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.